The ASPSCR1-TFE3 fusion gene is believed to cause aberrant activation of TFE3, which is thought to promote angiogenesis, cell proliferation, differentiation, and inhibiting apoptosis, thereby potentially contributing to tumorigenesis and tumor progression (53). This evidence concerns the gene TFE3 and neoplasm.